Pidotimod-containing pharmaceutical composition and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of pidotimod and its composition, which is applied in the field of pharmaceutical composition containing pidotimod and its preparation, and can solve problems such as discomfort of patients and inaccurate dose control
Inactive Publication Date: 2009-12-30
STAR LAKE BIOSCI CO INC ZHAOQING GUANGDONG
View PDF0 Cites 8 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, the immunostimulant pidotimod has been widely used clinically. Clinicians can use appropriate antibacterial drugs and pidotimod combined therapy according to the strains of the patient’s infection. bring a lot of discomfort to patients
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0010] Example 1 Pidotimod and Cloxacillin Tablets
[0011] prescription:
[0012]
[0013] Preparation:
[0014] Pass pidotimod and microcrystalline cellulose through an 80-mesh sieve, mix well, and set aside; take another appropriate amount of 50% ethanol solution, add cloxacillin to dissolve, use this solution as an adhesive to make a soft material, and use a 24-mesh sieve Granulate, dry at 50°C, sieve through a 20-mesh sieve, add micropowder silica gel and CMS-Na, mix well, and press a suitable die to form a tablet.
[0015] If the above-mentioned tablet is coated, a coated tablet can be obtained, which can be a film-coated tablet, an enteric-coated tablet, and the like.
[0016] Care should be taken to avoid light during the above operations.
Embodiment 2
[0017] Embodiment 2: pidotimod and roxithromycin capsules
[0018] prescription:
[0019]
[0020] Preparation:
[0021] Pass pidotimod through an 80-mesh sieve, mix it with starch evenly, and set aside; take another appropriate amount of 50% ethanol solution, add roxithromycin to dissolve it, use this solution as an adhesive to make a soft material, and make it through a 24-mesh sieve Granules, dried at 50°C, sieved with 20 meshes, added magnesium stearate, mixed evenly, packaged separately, and obtained.
[0022] The used capsule shell can be a common capsule or an enteric-coated capsule.
[0023] The above steps should be strictly protected from light.
Embodiment 3
[0024] Embodiment 3: pidotimod and cefaclor soft capsules
[0025] prescription:
[0026]
[0027] Preparation:
[0028] Dissolve cefaclor and pidotimod in PEG 400, add propylene glycol, stir well, adjust the weight of the contents, and press.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides a pidotimod-containing pharmaceutical composition and a preparation method thereof. The pidotimod-containing pharmaceutical composition consists of pidotimod and any antibacterial medicament. The antibacterial medicament may be any of beta-lactams (including as penicillins, cephems and unclassical beta-lactams), aminoglycosides, polymyxins, macrolides, lincomycins, norvancomycins, tetracyclines, chloromycetins, artificial antibacterial medicaments (including sulfonamides, quinolones and furofurans), cholesterols and antiviral medicaments. The unit dosage of the pidotimod is 0.1 to 2 grams, preferably 0.4 to 0.8 gram. The dosage of the antibacterial medicament is determined according to the dosage range of the antibacterial medicament. The composition of the pidotimod and the antibacterial medicament can exogenously and directly kill pathogenic bacteria through the antibacterial medicament and mobilize endogenous anti-infection immunity through an immunomodulator to improve anti-inflection effect, and has excellent synergy.
Description
technical field [0001] The invention relates to a pharmaceutical composition containing pidotimod and a preparation method thereof, belonging to the technical field of medicine. Background technique [0002] Pidotimod is an immune enhancer, which can promote both non-specific immune response and specific immune response. Pidotimod can promote the phagocytic activity of macrophages and neutrophils, improve their chemotaxis; activate natural killer cells; promote the proliferation of lymphocytes caused by mitogens, and reduce the helper T cells ( Ratio of CD4+) to suppressor T cells (CD8+) returns to normal; promotes cellular immune response by stimulating interleukin-2 and gamma-interferon. Animal experiments and clinical experiments have shown that although pidotimod has no direct antibacterial and antiviral activity; it can play a significant role in the treatment of bacteria (pneumococcus, Escherichia coli, Pseudomonas aeruginosa, Proteus, etc.) Efficacy of fungal and vi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more